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Abstract
Introduction: IL-10 is a very important anti-inflammatory cytokine. However, the role of this cytokine in T cells in
the pathogenesis of collagen-induced arthritis is unclear. The purpose of this study was to define the role of IL-10
signaling in T cells in the pathogenesis of collagen-induced arthritis.
Methods: IL-10 receptor dominant-negative transgenic (Tg) and control mice were immunized with bovine type II
collagen to induce arthritis. The severity of arthritis was monitored and examined histologically. T-cell activation
and cytokine production were analyzed using flow cytometry. T-cell proliferation was examined by [
3H]thymidine
incorporation. Antigen-specific antibodies in serum were measured by ELISA. Foxp3 expression in CD4
+ regulatory
T cells (Tregs) was determined by intracellular staining or Foxp3-RFP reporter mice. The suppressive function of
Foxp3
+CD4
+ Tregs was determined in vitro by performing a T-cell proliferation assay. The level of IL-17 mRNA in
joints was measured by real-time PCR. A two-tailed nonparametric paired test (Wilcoxon signed-rank test) was used
to calculate the arthritis and histological scores. Student’s paired or unpaired t-test was used for all other statistical
analyses (InStat version 2.03 software; GraphPad Software, San Diego, CA, USA).
Results: Blocking IL-10 signaling in T cells rendered mice, especially female mice, highly susceptible to collagen-
induced arthritis. T-cell activation and proliferation were enhanced and produced more IFN-g. The suppressive
function of CD4
+Foxp3
+ regulatory T cells was significantly impaired in Tg mice because of the reduced ability of
Tregs from Tg mice to maintain their levels of Foxp3. This was further confirmed by transferring Foxp3-RFP cells
from Tg or wild-type (Wt) mice into a congenic Wt host. The higher level of IL-17 mRNA was detected in
inflammatory joints of Tg mice, probably due to the recruitment of IL-17
+gδ T cells into the arthritic joints.
Conclusion: IL-10 signaling in T cells is critical for dampening the pathogenesis of collagen-induced arthritis by
maintaining the function of Tregs and the recruitment of IL-17
+gδ T cells.
Introduction
Rheumatoid arthritis (RA) is an autoimmune disease
characterized by chronic inflammation of the joint cap-
sule and synovial membrane which results in cartilage
injury, bone erosion and eventually joint destruction and
deformity [1]. Collagen-induced arthritis (CIA) is a well-
established animal model that has been studied exten-
sively because of its similarities to human RA [2].
Although the etiology of RA remains unknown, it has
been reported that a functional imbalance between
proinflammatory cytokines and regulatory T cells
(Tregs) is a key mechanism that underlies joint inflam-
mation and disease progression in CIA as well as RA
[3].
IL-10 is a pleiotropic cytokine with important
immune-regulatory functions [4]. It has been implicated
to have a potent anti-inflammatory role in several auto-
immune disease models, including CIA [5]. IL-10 sup-
presses the expression of inflammatory cytokines such
as TNF-a, IL-6 and IL-1 by activated macrophages [6].
IL-10 also affects T-cell proliferation and cytokine pro-
duction [7,8]. Indeed, IL-10 affects many of the cell
types in the immune system; however, the precise role
of IL-10 signaling in CD4
+ T cells in the pathogenesis
of CIA has not been addressed.
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human studies that naturally occurring CD4
+CD25
+Foxp3
+ Tregs play a critical role in the prevention of
autoimmunity and inflammatory arthritis [9,10]. Deple-
tion of CD4
+CD25
+ T cells aggravated CIA [11,12],
whereas transferring CD4
+CD25
+ cells to a disease-bear-
ing animal ameliorated arthritis [12]. Although it has
been well-documented that IL-10 can induce differentia-
tion of naïve CD4
+ Tc e l l si n t oC D 4
+IL-10
+ Tr1 cells
[13,14], it is unclear whether IL-10 signaling in T cells
affects the development or function of these Tregs.
Recently, a new subset of IL-17-producing CD4
+ T
cells, also called Th17 cells [15,16], has been implicated
as an important mediator in tissue inflammation [17].
IL-17-deficient mice showed markedly suppressed CIA
[18]. Resistance to CIA in p19
-/- mice correlated with an
absence of IL-17-producing CD4
+ T cells, suggesting
that the IL-23-IL-17 axis rather than the IL-12-IFN-g
axis is essential in promoting the development of CIA
[19]. It has been reported that IL-10 suppresses Th17
cytokine secretion by macrophages and T cells in in
vitro culture [20]. However, the role of IL-10 signaling
in T cells in the differentiation of Th17 cells and how
this regulation affects the pathogenesis of CIA is less
clear.
In this study, in which we studied previously described
IL-10 receptor dominant-negative transgenic (Tg) mice
[21], we showed that when T cells fail to respond to IL-
10, mice develop more severe arthritis and T cells are
more activated and proliferate more against type II col-
lagen (CII) antigen. Moreover, the suppressive function
of Tregs in these Tg mice was significantly impaired as
a result of attenuated expression of Foxp3. IL-10 signal-
ing in CD4
+ T cells might affect the cytokine profiles of
CD4
+ T cells as well as gδ T cells. These results indicate
that IL-10 signaling in T cells is the key to the patho-
genesis of CIA.
Materials and methods
Mice
D B A / 1a n dC 5 7 B L / 6m i c e( Thy1.2 or Thy1.1 back-
ground) were purchased from The Jackson Laboratory
(Bar Harbor, ME, USA) and maintained under specific
pathogen-free conditions at the Yale University School
of Medicine. DBA/1 background IL-10 receptor domi-
n a n t - n e g a t i v eT gm i c ew e r eo b t a i n e db yb a c k c r o s s i n g
C57BL/6 Tg mice [21] with wild-type (Wt) DBA/1 mice
for nine generations. The H-2
q/q and Tg genotypes were
screened by PCR using tail DNA. The IL-10 GFP
knockin mouse, designated IL-10-internal ribosomal
entry site (IRES)-GFP-enhanced reporter (Tiger), and
the Foxp3 red fluorescent protein (RFP) knockin mouse,
designated Foxp3-IRES-mRFP (FIR) mice, were
described previously [22,23]. All the animal procedures
were performed with the approval of the Institutional
Animal Care and Use Committee of the Yale University
School of Medicine.
Reagents
Bovine CII for immunization,T - c e l lp r o l i f e r a t i o na n d
E L I S A ,a sw e l la sC o m p l e t eF r e u n d ’sA d j u v a n t( C F A )
and Incomplete Freund’s Adjuvant (IFA), were all pur-
chased from Chondrex (Redmond, WA, USA). BD Gol-
giPlug and antibodies for flow cytometry were
p u r c h a s e df r o mB D( S a nD i e g o ,C A ,U S A ) .AF o x p 3
intracellular staining kit was purchased from eBioscience
(San Diego, CA, USA). Cytokines and antibodies for T-
cell differentiation in vitro were obtained from R&D
Systems (Minneapolis, MN, USA). Phorbol 12-myristate
13-acetate (PMA) and ionomycin were purchased from
Sigma-Aldrich (St Louis, MO, USA).
Collagen-induced arthritis model
The CIA model was employed as described previously
[ 2 4 ] .B r i e f l y ,1 0 0μg of bovine CII dissolved in 0.1 M
acetic acid was emulsified with 100 μlo fC F Ac o n t a i n -
ing 2 mg/ml inactivated Mycobacterium tuberculosis.
Mice were sensitized by intradermal injection at the
base of the tail and boosted at day 21 with the same
dose of CII and IFA intradermally. Mice were scored
blindly for disease severity every other day after the
boost using a grading scale from 0 to 3 that was
described previously [24]. Each paw was graded with a
maximum score of 12 per mouse.
Cell proliferation
Splenocytes from CIA mice were cultured with different
concentrations of CII for 3 days. After pulsing with 1
μCi of [
3H]thymidine per well for the last 18 hours, pro-
liferation was measured as radioactivity incorporation
(counts per minute (cpm)).
Activation markers
Splenocytes from CIA mice were stained with anti-CD3,
anti-CD4, anti-CD8, anti-CD44 and anti-CD62L antibo-
dies, and the surface markers for activation in CD4
+ and
CD8
+ T cells were analyzed using an LSR II flow cyt-
ometer (BD).
ELISA for serum anti-CII antibodies and their isotypes
Serum samples were collected from different groups of
immunized mice at different days postimmunization
(days 0, 14, 28, 35 and 42), the levels of anti-CII anti-
body in different isotypes were measured by ELISA as
described in our previous studies [25]. Briefly, ELISA
plates were coated with bovine CII (0.5 μg/well). After
the plates were blocked with 5% fetal bovine serum-
PBS, 1:800 diluted (with blocking buffer) mouse sera
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at room temperature. The plates were then washed, and
biotin-conjugated goat anti-mouse immunoglobulin G
(IgG), IgG1 and IgG2a were added at a dilution of
1:2,000 for 1 hour, followed by the addition of streptavi-
din-horseradish peroxidase (Sigma-Aldrich). The plates
were then developed, and antibody levels were measured
as described previously [24].
Quantitative real-time PCR
Total RNA was isolated from joints by using the RNeasy
Mini Kit (QIAGEN, Valencia, CA, USA). Genomic DNA
was removed by digestion with DNase I. cDNA was
synthesized using the iScript cDNA Synthesis Kit (Bio-
Rad Laboratories, Hercules, CA, USA), and gene expres-
sion was examined using the Stratagene Mx3005P
QPCR System with Brilliant SYBR Green QPCR Master
Mix reagent (both from Agilent Technologies, Inc, Santa
Clara, CA, USA). The data were normalized to a gapdh
reference [26]. The forward and reverse primers for il17
and gapdh were as follows [27]: il17,
TTTAACTCCCTTGGCGCAAAA, CTTTCCCTCCG
CATTGACAC; and gapdh, TTCACCACCATGGA-
GAAGGC, GGCATGGACTGTGGTCATGA.
Intracellular Foxp3 and cytokine staining
Single-cell suspensions were prepared from spleens,
lymph nodes or thymi and stained with surface CD4
and CD25. After being fixed with freshly prepared fixa-
tion/permeabilization solution at 4°C for at least 30
minutes in the dark, cells were blocked with Mouse BD
Fc Block (BD) in permeabilization buffer at 4°C for 15
minutes and stained with anti-Foxp3 antibody at 4°C for
30 minutes. For intracellular cytokine staining, cells
were stimulated with PMA plus ionomycin in the pre-
sence of brefeldin A for 4 hours. Cytokine production
was measured as described previously.
Suppression assay
Enriched CD4
+ T cells were sorted into a CD4
+CD25
+
subset as the regulatory cells and a CD4
+CD25
- subset
as the responder cells. T-cell-free splenocytes treated
with mitomycin C were used as antigen-present cells
(APCs). The responder cells were cultured with the reg-
ulatory cells at ratios of 1:1, 1:0.5, 1:0.25 and 1:0.125 or
without the regulatory cells as the positive control in
the presence of 2 μg/ml anti-CD3 antibody for 3 days in
96-well U-bottom plates, and APCs were added with the
responder cells at a 5:1 ratio. After pulsing with 1 μCi
of [
3H]thymidine per well, proliferation was measured as
radioactivity incorporation. The suppressive efficiency
was calculated using the following formula: percentage
suppression = (cpm of positive control) - (cpm of
experiment)/(cpm of positive control) × 100.
Adoptive transfer
CD4
+RFP
+ Tregs were sorted from the spleens of B6
Thy1.1 IL-10 dominant-negative receptor Tg and Wt
mice and were transferred into B6 Thy1.2 Wt mice at
equal cell numbers. One day after transfer mice were
i m m u n i z e dw i t hC F Aa n db o v i n eC I Ia sd e s c r i b e d
above. One week after immunization Foxp3 expression
in transferred cells was analyzed by checking the levels
of RFP.
Histopathologic assessment
O nd a y5 8a f t e rC I Ai n d u c t i o n ,m i c ew e r ek i l l e da n d
their paws were dissected free and used for histologic
examination. The joints were immediately fixed in 10%
buffered formalin and decalcified in a decalcifying solu-
tion for about 3 to 5 days [24]. The tissues were then
processed and embedded in paraffin. Five-micrometer
tissue sections were prepared and stained with H & E
using standard methods. All sections were stained at the
Yale Pathology Laboratory. Sections were blindly
observed and scored by histologists. Five arthritis sever-
ity factors were assessed using a grading scale from 0
(normal) to 5 (severe), based on a previously described
scoring system [28].
Statistical analysis
Data presented are means ± SEM. Statistical testing was
two-tailed with a 5% level of significance. A two-tailed
nonparametric paired test (Wilcoxon signed-rank test)
was used to analyze the arthritis and histologic scores.
Student’s paired or unpaired t-test was used for all
other statistical analyses (InStat version 2.03 software;
GraphPad Software, San Diego, CA, USA).
Results
Blocking IL-10 signaling in T cells rendered mice highly
susceptible to collagen-induced arthritis
To define the role of IL-10 signaling in T cells in the
pathogenesis of CIA, we employed newly generated IL-
10 receptor dominant-negative Tg mice in which T
cells expressed high levels of Tg IL-10Ra that were
truncated to remove its signaling domain [21]. Tg
mice were backcrossed with DBA/1 mice 10 times to
develop Tg mice on the CIA-susceptible background
(DBA/1, H-2
q). Four groups of DBA/1 mice (male Wt
or Tg and female Wt or Tg) from the same cohort of
littermates at age 8 weeks were immunized with
bovine CII to induce arthritis using the standard CIA
protocol described in our previous studies. It has been
o b s e r v e dt h a te v e ni nt h es u s c e p t i b l es t r a i no fm i c e ,
such as DBA/1 (H-2
q), female mice are more resistant
than male mice, with a lower incidence and less sever-
ity of CIA [28]. As expected, our experiment showed
that male mice were highly susceptible to and females
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mice developed progressive disease (with 100% inci-
dence) and had a mean arthritis score of 8.25 ± 2.88
(n = 10) on day 35 postimmunization. In contrast, all
t h ef e m a l eW tm i c ed e v e l o p e dv i s i b l ea r t h r i t i s( a l s o
100% incidence) with a significantly lower mean arthri-
tis score of 5.00 ± 4.10 (n = 12) on day 35 postimmu-
nization. Interestingly, female Tg mice developed
severe progressive disease and had a mean arthritis
score of 8.78 ± 2.33 (n = 10), slightly higher than
t h o s ep a r a m e t e r si nm a l eW tm i c ea n dm a l eT gm i c e
(7.89 ± 2.49, n = 12). Further evidence in support of
increased arthritis severity in female Tg mice was
obtained by histopathologic analysis. On day 50 post-
immunization, female Tg mice exhibited robust pannus
formation and significant articular cartilage erosion,
with pannus eroding and replacing the articular
cartilage overlying the bone. In contrast, Wt female
mice exhibited well-preserved joint spaces and articular
cartilage surfaces, with minimal pannus formation.
Among male mice, both Wt and Tg exhibited exten-
sive pannus formation and destruction of bone and
cartilage. One representative example is shown in Fig-
ure 1B. At 50 days postimmunization, the histologic
s c o r eo fW tf e m a l em i c ew a s3 . 8±1 . 4o fap o s s i b l e
score of 25. All the other groups showed similar scores
(Figure 1C) (female Tg, 13.7 ± 0.6; male Wt, 14.7 ±
0.8; male Tg, 13.3 ± 1.0, respectively; n =4m i c ei n
each group). Because the major difference in CIA dis-
ease severity was observed between female Wt and Tg
mice rather than male Wt and Tg mice, only female
mice were used for the rest of our study. Thus our
data suggest that IL-10 signaling in T cells plays a cri-
tical role in suppressing the pathogenesis of CIA.
A
Tg Wt
C
l
i
n
i
c
 
S
c
o
r
e
Days Post Immunization
Male p>0.05 Female
p<0.01
B
Female
Male
Wt Tg
C
*
H
i
s
t
o
l
o
g
i
c
a
l
 
S
c
o
r
e
Female Male
Wt
Tg
P<0.01
Figure 1 IL-10 receptor dominant-negative transgenic mice were highly susceptible to collagen-induced arthritis (CIA). (A) Sex- and
age-matched DBA/1J transgenic (Tg) and wild-type (Wt) littermate control mice were immunized with bovine type II collagen as described in
“Materials and methods.” The clinical arthritis score was observed, scored and recoded daily. Left (Wt males, n = 10, Tg males, n =9 ;P > 0.05).
Right (Wt females, n = 12, Tg females, n = 13; P < 0.01). The results of one of three repeated experiments are shown. (B) Representative H & E-
stained sections of paw joints from Wt and Tg mice on day 50 postimmunization in CIA animals are shown (original magnification, ×10; scale
bar, 100 μm). (C) Histological scores of paw joints on day 50 postimmunization. Each feature of arthritis (joint space exudate, synovitis, pannus
formation and cartilage and bone degradation) was graded from 0 (normal) to 5 (severe). The values given are means and SEM (n = 4 per
group; females, P < 0.01, and males, P > 0.05). The results are representative of two experiments.
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proliferation responses in collagen-induced arthritis mice
Activation and cytokine production of CD4
+ T cells play
an important role in the pathogenesis of CIA. To define
the underlying mechanisms of increased arthritis sever-
ity in female Tg mice, T-cell activation and proliferation
in CIA mice were first analyzed. Cells from draining
lymph nodes on day 50 postimmunization were stained
with anti-CD3, anti-CD4, anti-CD8, anti-CD44 and anti-
CD62L antibodies. After gating on CD3
+ T cells, the
CD44
hi T cells were recognized as activated cells. Acti-
vated CD4
+ was found to be significantly higher in Tg
mice than in Wt mice (Figure 2A, left), whereas acti-
vated CD8
+ in Tg and Wt mice appeared to be compar-
able (Figure 2A, right), implying that IL-10 signaling in
T cells controlled CD4
+ T cell activation in inflamma-
tory response. One representative dot plot is shown
(Figure 2B). To test the impact of IL-10 signaling in
antigen-specific T-cell proliferative response in immu-
nized mice, cells recovered as described above were cul-
tured in 96-well U-bottom plates in the presence of
different concentrations of CII for 3 days, followed by
pulsing with 1 μCi of [
3H]thymidine per well for the last
18 hours, and proliferation was measured as radioactiv-
ity incorporated (in cpm). Cells from Tg mice showed
significantly increased proliferative responses to specific
antigen (Figure 2C), suggesting a critical role of IL-10
signaling in T cells in controlling lymphocyte cell prolif-
eration in CIA. To further test whether IL-10 signaling
in T cells would affect T-cell differentiation in CIA, we
also analyzed IFN-g-producing CD4
+ T cells in draining
lymph nodes upon immunization and found elevated
percentages of IFN-g
+CD4
+ cells in Tg mice (Figure
2D), suggesting that IL-10 signaling suppressed the
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Figure 2 Altered T-cell phenotype in IL-10 dominant-negative receptor transgenic mice upon induction of collagen-induced arthritis.
(A) Sex- and age-matched DBA/1 transgenic (Tg) and wild-type (Wt) littermate control mice were immunized with type II collagen as described
in “Materials and methods.” Cells from draining lymph nodes in female DBA/1 mice on day 28 postimmunization were analyzed for CD44 and
CD62L expression after gating on CD4
+ (left) or CD8
+ T cells (right). Wt, n = 3, Tg, n =3 ;* P < 0.05. (B) One representative stain of CD44, CD62L
in CD3
+CD4
+ (left) and CD3
+CD8
+ (right) T cells of three repeated experiments is shown. (C) The same sources of cells described above were
cultured with different concentrations of collagen for 3 days. After pulsing with 1 μCi of [
3H]thymidine per well for the last 18 hours, proliferation
was measured as radioactivity incorporation in counts per minute (cpm). Stimulation Index = cpm experiment/cpm control (concentration of
collagen = 0). The results of one representative experiment are shown. (D) The cells were also stimulated with phorbol 12-myristate 13-acetate
(50 ng/ml) and ionomycin (500 ng/ml) in the presence of BD GolgiPlug for 4 hours then stained with CD4 and intracellular IFN-g. The statistical
analysis for the percentage of IFN-g
+ cells in the CD3
+CD4
+ gate is shown (Wt, n = 3, Tg, n =3 ;P < 0.05). One representative stain is shown (E).
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shown (Figure 2E). Interestingly, no significant differ-
ences were observed in terms of the numbers and the
activation states of gδ T cells in the spleens and draining
lymph nodes of Wt and Tg mice (data not shown).
Impaired suppressive function of regulatory T cells from
transgenic mice
It has been demonstrated that CD4
+Foxp3
+ Tregs play
important roles in the suppression of CIA in animal
models and human studies [9,10]. To define the role of
IL-10 signaling in T cells in the development of natu-
rally occurring Tregs (nTregs), the percentage and abso-
lute number of CD4
+CD25
+Foxp3
+ T cells in DBA/1
and B6 Tg and Wt mice were analyzed. Very similar
percentages and numbers of CD25
+Foxp3
+ T cells were
found in both Wt and Tg mice (Figures 3A and 3B),
indicating that IL-10 signaling in T cells was not
required for the development of nTregs. Similar results
were observed in DBA/1 mice upon immunization (data
not shown). To further define the function of Tregs, a
standard in vitro T-cell suppression assay was per-
formed. CD4
+CD25
+ T cells were sorted from B6 Wt or
Tg mice as Tregs and CD4
+CD25
- T cells from B6 Wt
mice as responders. Tregs from both Wt and Tg mice
were anergic to TCR activation (data not shown). Inter-
estingly, the suppressor function of Tregs from Tg mice
was significantly impaired in comparison to those from
Wt mice (Figures 3C and 3D). To rule out the contami-
nation of activated CD4
+ T cells in the Treg population
when using CD25 as the marker of Tregs, RFP-Foxp3
reporter mice [23] were used to sort Foxp3
+ regulators
and Foxp3
- responders and the suppress assay men-
tioned above was repeated. Similar results were obtained
(Figure 3E). Our results demonstrate that IL-10 signal-
ing in T cells is not required for Treg development, but
rather for T cells’ suppressive function.
IL-10 signaling in T cells is required for maintenance of
Foxp3 expression
To define the mechanisms underlying the reduced sup-
pressive function of Tregs in Tg mice, we first analyzed
IL-10 production in Tregs. For this purpose, we used IL-
10-Foxp3 double-reporter mice [22,23]. The percentage
of IL-10-expressing cells was similar between Wt and Tg
mice in both unimmunized and immunized states (Fig-
ures 4A and 4B), indicating that IL-10 signaling in T cells
was not required for IL-10 production by Tregs and that
IL-10 was not related to the impaired suppressive func-
tion of Tg Tregs. We next analyzed the transforming
growth factor (TGF)-b production by Tregs in Wt and
the Tg mice. Lymphocytes from Wt and the Tg mice
were stimulated with PMA and ionomycin for 4 hours in
the presence of brefeldin A, and intracellular Foxp3 and
TGF-b were stained in the CD4
+ T cell population. No
significant differences in TGF-b production between
Tregs from Wt and the Tg mice were detected (Figure
4C), suggesting that IL-10 signaling in T cells was not
involved in TGF-b production. We then investigated
whether IL-10 signaling in T cells would affect CTLA-4
expression level in Tregs. Cells from the lymph nodes of
unimmunized and immunized Wt and the Tg mice were
stained with Foxp3 and intracellular CTLA-4. CTLA-4
was highly expressed in CD4
+Foxp3
+ T cells, but not in
CD4
+Foxp3
- T cells; however, no significant differences
were found in the levels of CTLA-4 in Tregs from Wt
and Tg mice (Figure 4D). Because Foxp3 has been
reported to be the master transcription factor controlling
Treg development and determining the suppressive func-
tion of Tregs [29-31], we studied whether IL-10 signaling
played any role in maintaining the stable expression of
Foxp3. Similarly to the results shown in Figure 3A, the
percentage of Foxp3
+ T cells was very similar between
Wt and Tg mice (Figure 4A, left). Interestingly, it
decreased by 30% upon immunization (Figure 4A, right,
and Figure 4E). A similar phenomenon was observed in
DBA/1 mice using intracellular staining (data not
shown). To define whether IL-10 signaling was critical
for the maintenance of Foxp3 expression in Tregs, CD4
+RFP
+ T cells from Wt and Tg Thy1.1 mice were sorted
and transferred to Thy1.2 Wt mice, followed by immuni-
zation with CII and CFA. One week later the transferred
cells were analyzed for expression of RFP. Transferred
Foxp3
+ cells were observed to become RFP
- cells in both
Tg and Wt Tregs (Figures 4F and 4G). However, Tregs
from Tg mice showed significantly higher percentages of
RFP
- cells than those from Wt mice, indicating that IL-10
signaling in Tregs was critical to maintaining the level of
Foxp3 expression upon immunization.
Increased IL-17
+ gδ T cells and joint IL-17 expression in
transgenic mice
IL-17 is a critical cytokine in the pathogenesis of CIA
[32]. To define the role of IL-10 signaling in T cells on
IL-17 production by CD4
+ T cells, we first compared
the IL-17
+CD4
+ T cells from unimmunized mice. We
found that Tg mice had increased Th17 cells in both
peripheral and central lymph organs (Figure 5A), sug-
gesting that IL-10 signaling negatively regulates naturally
occurring Th17 cell development in steady state. To
further define the role of IL-10 in Th17 cell differentia-
tion, we sorted naïve CD4
+ Tc e l l s( C D 4
+CD44
lo
CD62L
hi cells) from Tg as well as IL-10-knockout (IL-
10Ko) mice versus Wt controls cultured under Th17
differentiation conditions in the presence or absence of
IL-10, and the cells were then used to analyze cytokine
production. No significant difference was found in terms
of the percentage of IL-17-producing cells among Tg,
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IL-10 signaling had no effect on inducible Th17 cell dif-
ferentiation (Figure 5B). To define the role of IL-17 in
local inflammatory response, the level of IL-17 mRNA
(il17) in the joints of CIA mice was analyzed using real-
time PCR. We found that joint tissues from Tg mice
expressed significantly higher levels of il17 than Wt
mice did (Figure 5C), which was consistent with the
severity of arthritis. To define the potential sources of
IL-17 in the joints, cells from draining lymph nodes of
CIA mice (Wt and Tg mice) were analyzed for IL-17A
production. Interestingly, significantly higher percen-
tages of gδ T cells from Tg mice produced IL-17 than
those from Wt mice (Figure 5D), especially CD44
hi gδ T
cells. In contrast, we did not find significant differences
in the number of IL-17-producing CD4
+ T cells (Figure
5E), suggesting gδ T cells as the primary source of IL-17
in the inflammatory joints.
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Figure 3 Impaired suppressive function of regulatory T cells from transgenic mice. (A) Splenocytes from C57BL/6 mice were stained with
anti-CD4 and anti-CD25 antibodies, which was followed by Foxp3 intracellular staining, as described in “Materials and methods.” The dot plots of
CD25
+ and Foxp3
+ proportions after gating on CD3
+CD4
+ T cells are shown. The results shown are from one of three representative
experiments. (B) The absolute number of regulatory T cells (Tregs) (CD4
+CD25
+Foxp3
+ cells) from the spleens of C57BL/6 mice were calculated
and are shown here (n = 3 mice for each group; P > 0.05). (C) CD4
+ T cells from the spleens of B6 wild-type (Wt) or transgenic (Tg) mice were
enriched and sorted into a CD4
+CD25
+ subset as the regulatory cells and a CD4
+CD25
- subset from Wt C57BL/6 as the responder cells. The
number of responder cells was fixed at 5 × 10
4. The inhibition function of Tregs was measured by in vitro assay as described in “Materials and
methods.” The percentage inhibition by different populations of Tregs was calculated by using the formula described in “Materials and methods.”
cpm, counts per minute. (D) The results shown are from one of three representative experiments. (E) B6 Wt and Tg mice were crossed with
Foxp3-RFP mice. CD4
+ T cells from the spleens of Wt or Tg red fluorescent protein (RFP) mice were enriched and sorted into a CD4
+RFP
+ subset
as the regulatory cells and a CD4
+RFP
- subset from Wt C57BL/6 as the responder cells. The responder cells (5 × 10
4/well) were cocultured with
an equal number of regulatory cells for the inhibition assay described above. The results from one of three representative repeated experiments
are shown.
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Page 7 of 13IL-10 signaling in T cells has no effect on antigen-specific
antibody response
Antibody production against CII is an important factor
in the development of CIA [33]. To define the impact of
IL-10 signaling in T cells on collagen-specific antibody
response, serum samples were collected from naïve mice
as well as from different groups of immunized mice at
different time points after immunization (days 0, 14, 28,
35 and 42), and the levels of anticollagen antibodies
were analyzed by ELISA as described in our previous
studies [24]. The level of collagen-specific antibody in
serum increased upon immunization and was main-
tained at high levels between days 14 and 42. Surpris-
ingly, there was no difference in collagen-specific
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Figure 4 IL-10 signaling is required for the maintenances of Foxp3 expression. (A) IL-10 GFP and Foxp3 red fluorescent protein (RFP) dual-
reporter mice (Tiger-Foxp3- internal ribosomal entry site-mRFP (Tiger-FIR) mice on C57BL/6 background) were crossed with B6 wild-type (Wt) or
transgenic (Tg) mice, and these mice were then also immunized with type II collagen (CII) according to the same protocol that we used for
collagen-induced arthritis. Upon gating on CD4
+ T cells, cells from the lymph nodes of unimmunized Wt and Tg mice were analyzed for RFP
and GFP expression (left). Cells from draining lymph nodes of Wt and Tg mice on day 28 after immunization with CII and Complete Freund’s
Adjuvant (CFA) were also analyzed (right). The results of one representative experiment are shown. (B) The percentages of CD4
+GFP
+ cells
among CD4
+RFP
+ cells in Wt and Tg mice described in (A) are shown (three mice in each group). Tregs, regulatory T cells. (C) Splenocytes from
B6 Wt and Tg mice (five mice in each group) were stimulated with phorbol 12-myristate 13-acetate and ionomycin for 4 hours. The expression
levels of Foxp3 and transforming growth factor b (TGF-b) were measured by intracellular staining. A representative example is shown for one of
three repeated experiments. (D) CTLA4 was analyzed by intracellular staining in CD3
+CD4
+Foxp3
+ and CD3
+CD4
+Foxp3
- cells from the lymph
nodes of unimmunized and immunized C57BL/6 Wt and Tg mice (day 28 after immunization with CII and CFA). The results shown are from one
of three repeated experiments. (E) B6 Wt and Tg Foxp3 RFP mice used in (A) were immunized with CII, with CFA or left untreated, and the
percentage of RFP
+ cells among gated CD4
+ cells in Wt and Tg mice are shown (three mice in each group). (F) RFP
+CD4
+ T cells were sorted
from B6 Thy1.1 Wt and Tg mice, transferred to B6 Thy1.2 Wt recipient mice and immunized with CII and CFA. One week later the level of Foxp3
expression in Thy1.1
+ cells from the host mice was analyzed on the basis of the percentage of RFP
+ cells (three mice in each group; P < 0.05).
(G) The results of one representative experiment of the three repeated experiments described in (F) are shown.
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Figure 5 Increased IL-17 mRNA expression in the joints of transgenic mice. (A) Cells from the lymph nodes and thymi of untreated B6
wild-type (Wt) or transgenic (Tg) mice were stimulated with phorbol 12-myristate 13-acetate (50 ng/ml) and ionomycin (500 ng/ml) in the
presence of BD GolgiPlug for 4 hours, followed by staining with TCRb, CD4, CD8, CD44 and intracellular IL-17. One representative stain is shown
(right). The statistical analysis of the percentage of IL-17
+ cells in TCRb
+CD4
+CD8
-CD44
hi cells (three mice in each group) is shown (left). (B)
Naïve CD4
+ T cells (CD4
+CD44
lowCD62L
hi) from B6 Wt, IL-10-knockout (IL-10Ko) and Tg mice were sorted and stimulated with coated anti-CD3
and anti-CD28 antibodies under Th17 differentiation conditions in the presence or absence of IL-10 (100 μg/ml). Seven days later IL-17
production was measured by intracellular staining. The results of one of three representative experiments are shown. (C) The relative levels of IL-
17 mRNA from the joints of DBA/1J Wt and Tg mice with collagen-induced arthritis (on day 50 postimmunization) were measured by real-time
PCR. (D) Cells from draining lymph nodes of immunized C57BL/6 Wt or Tg mice (on day 7 postimmunization) were stimulated with the same
procedure described above for IL-17 intracellular staining. One representative stain showing lymphocytes (left) or CD3
+TCRδ
+ T cells (middle)
upon gating is shown. The statistical analysis for the percentage of IL-17
+ cells in CD3
+TCRδ
+ cells (three mice in each group) is shown (right).
(E) The same population of cells described in (D) was also stimulated for IL-17 intracellular staining upon gating on lymphocytes (left) or CD4
+ T
cells (middle). Statistics analysis for the percentage of IL-17
+ cells in TCRb
+CD4
+CD8
-CD44
hi cells (three mice in each group) is shown (right).
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Page 9 of 13antibodies, including the total IgG, IgG1 and IgG2a iso-
types, among Wt and Tg mice (Figure 6). These results
suggest that blocking IL-10 signaling in T cells has no
direct effect on collagen-specific antibody production by
B cells in a CIA model.
Discussion
T h eC I Ah a sb e e nu s e da sam o d e lf o rs t u d y i n gt h e
pathogenesis and potential application of novel thera-
peutic agents for human RA. Both T and B cells are
essential for the development of RA [34,35], and IL-10
plays different roles in regulating the function of T and
B cells [36]. It is therefore important to study the
unique role of IL-10 signaling in T cells (without affect-
ing B cells) in the pathogenesis of CIA. In this study, we
demonstrated that IL-10 signaling in T cells play a
critical role in the pathogenesis of CIA by affecting the
function of Tregs by stabilizing the expression of Foxp3.
To target IL-10 signaling selectively in T cells, a
unique IL-10 receptor dominant-negative Tg mouse was
recently developed with the Tg under the control of
CD4 promoter, which lacks the CD8 silencer element
and therefore is expressed in both CD4
+ and CD8
+ T
cells [21]. In these mice, CD4
+ and CD8
+ T cells
expressed high levels of the Tg IL-10Ra, which lacks the
cytoplasmic domain. As this receptor functions as a
dominant-negative receptor, its responsiveness to IL-10
is attenuated in these T cells. Using these mice, we
demonstrated that Tg mice developed more severe
arthritis upon induction in the absence of IL-10 signal-
ing (Figure 1). This was especially true for female mice.
Even in susceptible strains, female Wt mice are more
Wt Tg
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Figure 6 IL-10 signaling in T cells has no effect on type II collagen-specific antibody production. Serum samples from DBA/1J Wt or Tg
mice (six mice in each group) were collected on days 0, 14, 21, 35 and 42 after collagen-induced arthritis induction, and collagen-specific
antibodies (immunoglobulin G (IgG), IgG1 and IgG2a) were detected by ELISA. The results of one representative experiment are shown.
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Page 10 of 13resistant than males, and the underlying mechanisms
have not been studied systematically. Our observation
that blockade of IL-10 signaling in T cells rendered
female mice highly susceptible to CIA may shed some
light on the molecular mechanisms of the gender differ-
ences. Of course, we did not rule out the possibility that
IL-10 signaling might also affect the male mice if these
mice were immunized with lower doses of CII and/or
subdoses of adjuvant. Further studies are needed to
explore this possibility.
CD4
+ T cells play an essential role in the pathogenesis
of CIA as well as RA. Autoreactive T cells are normally
controlled by Tregs and other regulatory mechanisms
under normal circumstances, whereas in autoimmune
diseases Treg dysfunction causes autoreactive T-cell
proliferative responses and tissue damage [37]. As one
of the key suppressive cytokines, IL-10 plays an impor-
tant role in controlling T-cell responses. Indeed, though
T cells were unable to respond to IL-10, they were
more activated and proliferated more vigorously upon
CIA induction, with a a more pronounced Th1 response
(Figure 2). Our data suggest that a potential mechanism
for this enhanced T-cell response could be the dysfunc-
tion of Tregs. Although IL-10 signaling in T cells was
not required for the development of nTregs (Figures 3A
and 4A), we clearly have demonstrated that the suppres-
sive function of Tregs was significantly impaired in the
absence of IL-10 signaling (Figures 3C and 3D).
Several elements are critical for the function of Tregs,
including IL-10, TGF-b and CTLA-4 [38]. To define
which factor was critical for the function of Tregs in
connection of IL-10 signaling in T cells, we analyzed the
levels of IL-10, TGF-b and CTLA-4 in Tregs of Wt and
the Tg mice. To our surprise, no significant differences
were detected between these two populations of Tregs
(Figure 4), implying that IL-10 signaling in T cells was
not required for the expression of these factors.
Foxp3 is a critical factor that determines not only the
development and differentiation but also the suppression
function of Tregs. Expression of Foxp3 can be regulated
by multiple factors, including inflammatory cytokines
[39]. One of the striking findings of our study is that we
have demonstrated that in the absence of IL-10 signal-
ing in T cells, the expression levels of Foxp3 were
reduced upon immunization, on the basis of both ex
vivo studies (Figure 4A) and Foxp3-RFP T-cell adoptive
transfer experiments (Figures 4F and 4G). This pheno-
type was observed in C57BL/6 mice as well as in DBA/1
mice, suggesting that Foxp3 downregulation in Tg mice
upon immunization may be associated with the disease
mechanism in CIA (data not shown). By taking advan-
tage of our Foxp3-RFP reporter mice, we were able to
isolate a pure population of Tregs and track these cells
in the congenic hosts. We speculated that upon
immunization, inflammatory cytokines might target
Tregs and regulate expression of Foxp3. One of the cri-
tical functions of IL-10 signaling in these Tregs probably
was to maintain the expression of this key molecule.
Therefore, our results collectively indicate that IL-10
signaling in T cells is critical for the function of Tregs
by maintaining the expression level of Foxp3. Although
Foxp3 is an X-linked gene, no significant difference was
observed in the expression levels of Foxp3 between male
and female mice (data not shown). Further studies are
needed to define the molecular mechanisms underlying
how the IL-10 signaling pathway maintains the expres-
sion of Foxp3.
IL-17 has been defined as a critical cytokine that med-
iates autoimmune inflammation, especially in CIA and
RA [40]. This has been evidenced by a series of studies
using different gene-deficient mice, including p19
-/-,
inducible costimulatory molecule (ICOS
-/-)a n dI L - 1 7
-/-
mice [18,19,40]. Indeed, the expression levels of IL-17A
were found to be significantly increased in the joints of
Tg mice, which correlated with severe arthritis (Figure
5). Interestingly, the increased levels of IL-17 were not
derived from CD4
+ T cells; rather, they were most likely
derived from gδ T cells (Figures 5D and 5E). Our results
are consistent with those of previous studies in that Vg4
gδ T cells provided IL-17A in the pathogenesis of CIA
[41]. How does IL-10 signaling in CD4
+ T cells affect
the production or recruitment of IL-17A-producing gδ
T cells is unclear at present. Several possibilities might
explain our findings. IL-10 signaling promoted both thy-
mic and peripheral CD4
+ T cells to produce IL-17A in
naïve, but not in immunized, mice (Figure 5A), indicat-
ing a possibility that IL-10 signaling might change the
threshold of IL-17 expression by CD4
+ T cells. The
increased percentage of IL-17
+ gδ T cells in the draining
lymph nodes of CIA mice could be a result of more
local differentiation, more recruitment from other tis-
sues, or both. Whether increased IL-17 production from
CD4
+ T cells in naïve mice has any impact on IL-17
production by gδ T cells upon immunization remains to
be determined.
We have to emphasize that IL-10 signaling in T cells
did not affect T-cell-B-cell collaboration or the produc-
tion of CII-specific antibodies (Figure 6). IL-10 has been
defined as a B-cell-stimulating factor and can promote
antibody production [42,43]. Because the function of T
cells but not B cells was affected in Tg mice [21], it was
not surprising that we saw no differences in autoanti-
body production between Wt and Tg mice. More gener-
a l l y ,t h i sT gm o u s em a yp r o v i d eau n i q u em o d e li n
which to study the dysfunction of T cells without affect-
ing antibody responses.
Our study clearly demonstrates that IL-10 signaling in
T cells is critical for the pathogenesis of CIA by
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Page 11 of 13maintaining the level of Foxp3 and consequently contri-
buting to the dysfunction of Tregs as well as to the
increased expression level of the innate source of IL-
17A by gδ T cells. Enhancement of IL-10 signaling in T
cells may regulate the function of Tregs, which can
dampen the harmful autoimmune responses.
Conclusions
Our results demonstrate a critical role of IL-10 signaling
in T cells in the pathogenesis of CIA. Without IL-10
signaling, T cells, especially Tregs, lost their suppressive
function, which in turn failed to control CD4
+ T-cell
activation. Enhancement of IL-10 signaling in T cells
might serve as a therapeutically sound approach to the
treatment of RA as well as other autoimmune inflamma-
tory diseases.
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